Ion Beam Applications SA (IBAB)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Ion Beam Applications SA (IBAB) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011164
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ion Beam Applications SA (IBA) is a medical technology company that develops solutions for the diagnosis and treatment of cancer. It offers monitoring equipment and software that enables hospitals to perform calibration procedures during radiation therapy and radiology. The company focuses its activities on proton therapy solutions, radiopharmacy solutions and particle accelerators. IBA’s products and services find application in the treatment of cancer and neurologic and cardiac disorders. It also provides sterilization and ionization solutions for industrial uses. The company has operational presence in North America, South America, Europe and Asia. IBA is headquartered in Louvain la Neuve, Walloon Brabant, Belgium.

Ion Beam Applications SA (IBAB) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Ion Beam Applications SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Ion Beam Applications SA, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Ion Beam Applications SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Ion Beam Applications SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Ion Beam Applications SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Ion Beam Applications SA, Medical Equipment, Deal Details 12
Venture Financing 12
HIL Applied Medical Raises Funds in Series C Financing 12
Private Equity 13
CapVest Partners Acquires IBA Molecular from Ion Beam Applications and SK Capital Partners for USD69.6 Million 13
Argos Soditic Completes Management Buyout Of Cisbio Bioassays For US$32.4 Million 14
SK Capital Partners Acquires 60% Stake In IBA Molecular Imaging From Ion Beam Applications For US$234 Million 16
Partnerships 18
Elekta to Enter into Agreement with IBA 18
Royal Philips, Singapore Institute of Advanced Medicine Forms Joint Venture with Varian Medical Systems and Ion Beam Applications 19
Ion Beam Applications Enters into Agreement with Koninklijke Philips 21
IBA Partners with Philips India 22
Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems 23
Ion Beam Applications Enters into Co-Development Agreement with Royal Philips 24
Ion Beam Applications Enters into Co-Development Agreement with Mobius Medical Systems 25
RaySearch And Ion Beam Applications Enter Into Agreement To Develop Proton Treatment Planning System 26
IBA Group Enters Into An Agreement With Royal Philips Electronics 27
IBA Dosimetry Enters Into Distribution Agreement With Axios Oncology 28
Acquisition 29
Ion Beam Applications Acquires 25% Stake In PET Net 29
Ion Beam Applications SA – Key Competitors 30
Ion Beam Applications SA – Key Employees 31
Ion Beam Applications SA – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 34
Strategy And Business Planning 34
Sep 25, 2016: IBA and Philips step up collaboration in adaptive proton therapy planning to advance personalized cancer care 34
Financial Announcements 35
Nov 16, 2017: IBA Trading Update – Third Quarter 2017 35
Aug 24, 2017: IBA Reports Half Year Results for 2017 37
May 10, 2017: IBA trading update – first quarter 2017 38
Nov 16, 2016: IBA Trading Update – Third Quarter 2016 39
Aug 25, 2016: IBA Reports Half Year 2016 Results 41
May 11, 2016: IBA Trading Update – First Quarter 2016 42
Feb 17, 2016: IBA announces 2016 guidance and upgrades 2015 expectations 44
Corporate Communications 45
Jun 02, 2016: IBA Strengthens Management Team For Future Growth 45
Government and Public Interest 46
Jun 14, 2016: Proton Therapy Arrives at Miami Cancer Institute 46
Product News 47
02/02/2016: HUPTI Advances Cancer Treatment to Another Level for Cancer Patients With the Addition of Pencil Beam Scanning 47
Other Significant Developments 48
Sep 27, 2016: IBA’s Proton Therapy Community Achieves the Next Big Milestone With 50,000 Cancer Patients Treated 48
Sep 23, 2016: IBA to open the path towards adaptive proton therapy 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Tables
Ion Beam Applications SA, Medical Equipment, Key Facts, 2016 2
Ion Beam Applications SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Ion Beam Applications SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Ion Beam Applications SA, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Ion Beam Applications SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Ion Beam Applications SA, Deals By Market, 2011 to YTD 2017 9
Ion Beam Applications SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
HIL Applied Medical Raises Funds in Series C Financing 12
CapVest Partners Acquires IBA Molecular from Ion Beam Applications and SK Capital Partners for USD69.6 Million 13
Argos Soditic Completes Management Buyout Of Cisbio Bioassays For US$32.4 Million 14
SK Capital Partners Acquires 60% Stake In IBA Molecular Imaging From Ion Beam Applications For US$234 Million 16
Elekta to Enter into Agreement with IBA 18
Royal Philips, Singapore Institute of Advanced Medicine Forms Joint Venture with Varian Medical Systems and Ion Beam Applications 19
Ion Beam Applications Enters into Agreement with Koninklijke Philips 21
IBA Partners with Philips India 22
Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems 23
Ion Beam Applications Enters into Co-Development Agreement with Royal Philips 24
Ion Beam Applications Enters into Co-Development Agreement with Mobius Medical Systems 25
RaySearch And Ion Beam Applications Enter Into Agreement To Develop Proton Treatment Planning System 26
IBA Group Enters Into An Agreement With Royal Philips Electronics 27
IBA Dosimetry Enters Into Distribution Agreement With Axios Oncology 28
Ion Beam Applications Acquires 25% Stake In PET Net 29
Ion Beam Applications SA, Key Competitors 30
Ion Beam Applications SA, Key Employees 31
Ion Beam Applications SA, Subsidiaries 32

★海外企業調査レポート[Ion Beam Applications SA (IBAB)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PhoenixBio Co Ltd (6190):企業の財務・戦略的SWOT分析
    Summary PhoenixBio Co Ltd (PhoenixBio) is a life science company that offers medical therapy solutions. The company offers contract study services including dosing of test-compounds, sampling, in-life phase trials, chemical analysis, measurement of human albumin levels, and metabolic enzymes and blo …
  • SeaBird Exploration PLC (SBX):企業の財務・戦略的SWOT分析
    Summary SeaBird Exploration PLC (SeaBird) operates as an oil and gas company that offers marine seismic data services. The company’s services include 2D seismic acquisition, 3D and 3D shallow water acquisition and source vessel. Its source vessels offers services such as conventional undershoots, 4d …
  • Pernix Therapeutics Holdings Inc (PTX):医療機器:M&Aディール及び事業提携情報
    Summary Pernix Therapeutics Holdings Inc (Pernix Therapeutics) is a specialty pharmaceutical company that discovers, develops, and markets generic pharmaceutical products. The company’s portfolio encompasses a fixed dose combination product prescribed to treat acute migraine; an extended-release (XR …
  • Terumo BCT Inc:企業の戦略的SWOT分析
    Terumo BCT Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Croatia Airlines dd:戦略・SWOT・企業財務分析
    Croatia Airlines dd - Strategy, SWOT and Corporate Finance Report Summary Croatia Airlines dd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • SONIFI Solutions, Inc:企業の戦略的SWOT分析
    SONIFI Solutions, Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • K2M Inc-医療機器分野:企業M&A・提携分析
    Summary K2M Inc (K2M), a subsidiary of K2M Group Holdings Inc is a medical device company that designs, develops and markets spine solutions products for the treatment of spinal pathologies. The company offers complex spine, minimally invasive, degenerative and biologics products. It offers complex …
  • Reynolds American Inc.:企業の戦略的SWOT分析
    Reynolds American Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Dynasty Fine Wine Group Limited:企業の戦略・SWOT・財務情報
    Dynasty Fine Wine Group Limited - Strategy, SWOT and Corporate Finance Report Summary Dynasty Fine Wine Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • AFC Energy plc (AFC):企業の財務・戦略的SWOT分析
    Summary AFC Energy Plc (AFC Energy) is a developer of alkaline fuel cells. The company's projects include Power-Up and Alkammonia. AFC Energy power generation technology is used in the industrial markets and produces heat, water, and electricity. The company provides its electricity for industrial a …
  • Cleveland BioLabs Inc (CBLI):企業の財務・戦略的SWOT分析
    Summary Cleveland BioLabs Inc (Cleveland) is a biopharmaceutical company that develops and commercializes drugs to treat cancer, orphan indications and protect healthy tissues from radiation and chemotherapy. The company’s product includes entolimod, a recombinant protein that acts as an agonist of …
  • Sernova Corp (SVA):製品パイプライン分析
    Summary Sernova Corp (Sernova) is a clinical stage regenerative medicines company which develops and commercializes medical device and combination products for the treatment of chronic diseases. The company is developing Cell Pouch System, an implantable medical device, which offers a natural organ- …
  • Ulta Salon, Cosmetics & Fragrance Inc:企業の戦略・SWOT・財務情報
    Ulta Salon, Cosmetics & Fragrance Inc - Strategy, SWOT and Corporate Finance Report Summary Ulta Salon, Cosmetics & Fragrance Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Interprotein Corp-製薬・医療分野:企業M&A・提携分析
    Summary Interprotein Corp (Interprotein) is a drug discovery company that conducts research and develops small molecule drugs. The company provides IL-6 inhibitor, IgE inhibitor, notch1 inhibitor, tubulin polymerization inhibitors, TIM-3 inhibitor, NKG2A, HLA-E and CD94 inhibitor; KIR and HLA-C inhi …
  • Innsuites Hospitality Trust:企業の戦略・SWOT・財務分析
    Innsuites Hospitality Trust - Strategy, SWOT and Corporate Finance Report Summary Innsuites Hospitality Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • General Dynamics United Kingdom Limited:企業の戦略・SWOT・財務情報
    General Dynamics United Kingdom Limited - Strategy, SWOT and Corporate Finance Report Summary General Dynamics United Kingdom Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • G&W Electric Co:企業の戦略的SWOT分析
    G&W Electric Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Dana Brevini SpA:企業の戦略・SWOT・財務情報
    Dana Brevini SpA - Strategy, SWOT and Corporate Finance Report Summary Dana Brevini SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • PetroMaroc Corporation Plc (PMA):企業の財務・戦略的SWOT分析
    Summary PetroMaroc Corporation Plc (Petromaroc), formerly Longreach Oil and Gas Ltd, is an oil and gas exploration and development company that evaluates, acquires, explores and develops oil and gas properties in Morocco. The company holds interests in the Sidi Moktar licence area which includes geo …
  • Kien Long Commercial Joint Stock Bank (KBC):企業の戦略的SWOT分析
    Kien Long Commercial Joint Stock Bank (KBC) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆